Literature DB >> 6404410

Clobazam as adjunctive treatment in refractory epilepsy.

J W Allen, J Oxley, M M Robertson, M R Trimble, A Richens, S S Jawad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6404410      PMCID： PMC1547272          DOI： 10.1136/bmj.286.6373.1246

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Anticonvulsant action of a 1,5-benzodiazepine, clobazam, in reflex epilepsy.

Authors:  A G Chapman; R W Horton; B S Meldrum
Journal:  Epilepsia       Date:  1978-06       Impact factor: 5.864

2.  Antiepileptic properties of clobazam, a 1-5 benzodiazepine, in man.

Authors:  H Gastaut; M D Low
Journal:  Epilepsia       Date:  1979-08       Impact factor: 5.864
  2 in total
  11 in total

1.  Development of tolerance to anticonvulsant effect of clobazam.

Authors:  J W Allen; S Jawad; J Oxley; M Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-03       Impact factor: 10.154

2.  PharmGKB summary: clobazam pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Steven Leeder; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2018-04       Impact factor: 2.089

Review 3.  Clobazam.

Authors:  Yu-tze Ng; Stephen D Collins
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 4.  Clobazam add-on therapy for drug-resistant epilepsy.

Authors:  Rebecca Bresnahan; Kirsty J Martin-McGill; John Williamson; Benedict D Michael; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

5.  Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.

Authors:  S Jawad; A Richens; J Oxley
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

6.  Valproic acid-induced abnormal behavior.

Authors:  Nanjangud Chandrashekar Nagalakshmi; Madhan Ramesh; Gurumurthy Parthasarathi; Anand Harugeri; Mary Sam Christy; Belur Seshachala Keshava
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 7.  Drug treatment of epilepsy. Outlines, criticism and perspectives.

Authors:  E Beghi; R Di Mascio; G Tognoni
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

8.  Epileptic seizure disorders. Developments in diagnosis and therapy.

Authors:  E Niedermeyer; W Froescher; R S Fisher
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

9.  Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Andres M Kanner; Eric Ashman; David Gloss; Cynthia Harden; Blaise Bourgeois; Jocelyn F Bautista; Bassel Abou-Khalil; Evren Burakgazi-Dalkilic; Esmeralda Llanas Park; John Stern; Deborah Hirtz; Mark Nespeca; Barry Gidal; Edward Faught; Jacqueline French
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

10.  Intermittent clobazam for catamenial epilepsy: tolerance avoided.

Authors:  M Feely; J Gibson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.